Literature DB >> 11459279

Palliative strategies for locally advanced unresectable and metastatic pancreatic cancer.

M Molinari1, W S Helton, N J Espat.   

Abstract

Technical improvement in perioperative morbidity and mortality with improved long-term survival associated with pancreaticoduodenectomy for patients with pancreatic carcinoma has clearly established a role for this operation when performed with curative intent. Most patients with pancreatic adenocarcinoma will not be candidates for surgical resection of their disease. These patients will experience significant symptoms potentially requiring surgical and nonsurgical palliative interventions to treat unrelieved cancer-associated pain, obstructive jaundice, or the development of GOO. The primary goal for palliative interventions should be to relieve symptoms with minimal morbidity and to maintain or improve the quality of life for patients with an expected limited survival.

Entities:  

Mesh:

Year:  2001        PMID: 11459279     DOI: 10.1016/s0039-6109(05)70151-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Racial/ethnic patterns of care for pancreatic cancer.

Authors:  Vickie L Shavers; Linda C Harlan; Monica Jackson; Jamuir Robinson
Journal:  J Palliat Med       Date:  2009-07       Impact factor: 2.947

2.  Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Authors:  John D Allendorf; Margaret Lauerman; Aliye Bill; Mary DiGiorgi; Nicole Goetz; Efsevia Vakiani; Helen Remotti; Beth Schrope; William Sherman; Michael Hall; Robert L Fine; John A Chabot
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

3.  Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.

Authors:  Deepa Bedi; James W Gillespie; Valery A Petrenko
Journal:  Protein Eng Des Sel       Date:  2014-06-04       Impact factor: 1.650

4.  High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.

Authors:  Milka Marinova; Maximilian Rauch; Martin Mücke; Roman Rolke; Maria A Gonzalez-Carmona; Jana Henseler; Henning Cuhls; Lukas Radbruch; Christian P Strassburg; Lian Zhang; Hans H Schild; Holger M Strunk
Journal:  Eur Radiol       Date:  2016-02-17       Impact factor: 5.315

Review 5.  Percutaneous ablation therapies of inoperable pancreatic cancer: a systematic review.

Authors:  Anna Maria Ierardi; Natalie Lucchina; Alessandro Bacuzzi; De Chiara Marco; Elena Bracchi; Eugenio Cocozza; Gianlorenzo Dionigi; Dimitrios Tsetis; Chiara Floridi; Gianpaolo Carrafiello
Journal:  Ann Gastroenterol       Date:  2015 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.